Benefits and risks of red blood cell transfusion in pediatric patients undergoing cardiac surgery

As the number of neonates and young infants undergoing cardiac surgery requiring cardiopulmonary bypass (CPB) increases, red blood cell (RBC) transfusion will continue to be an integral part of the practice of pediatric cardiac anesthesiology. The decision of when to transfuse RBCs to these patients is complex and influenced by multiple factors such as size, presence of cyanotic heart disease, complexity of the surgical procedure, and the hemostatic alterations induced by CPB. The known benefits of RBC transfusion include an increase in the oxygen-carrying capacity of blood, improved tissue oxygenation, and improved hemostasis. Unfortunately, there is no minimum hemoglobin level that serves as a transfusion trigger for all pediatric patients undergoing cardiac surgery. Physiologic signs such as tachycardia, hypotension, low mixed venous oxygen saturation and increased oxygen extraction ratios can provide objective evidence of the need to augment a given hemoglobin level. Nevertheless, the benefits of RBC transfusion must be balanced against its risks and, in recent years, RBC transfusion has been subjected to intense scrutiny. The adverse consequences of RBC transfusion include the transmission of infectious diseases and immune-mediated and nonimmune-mediated complications. Advances in donor selection, infectious disease testing of donated blood, use of leukocyte reduction and irradiation of blood in defined situations have improved the safety of the blood supply in terms of infection transmission. However, a growing number of prospective randomized clinical trials are finding an association between RBC transfusion and an increased risk of morbidity and mortality even with the use of leuko-reduced blood. Thus, it is becoming increasingly important that the decision to transfuse RBCs be made with a thorough understanding of the benefit-to-risk ratio. This review addresses the benefits and risks of RBC transfusion, pertinent data acquired in the setting of congenital cardiac surgery and techniques designed to minimize the need for RBC transfusion.     

腰椎后路融合内固定术围手术期输注悬浮红细胞的危险因素分析

目的 探讨行腰椎后路融合内固定术病人围手术期输注悬浮红细胞的危险因素。方法 回顾性分析2016年1月至2018年6月在广州市番禺区中医院骨伤科施行腰椎后路融合手术的468例病人的临床资料,选取性别、年龄、身体质量指数（body mass index, BMI）、吸烟史、饮酒史、糖尿病、高血压、肺部疾病、心脏疾病、肾脏疾病、骨质疏松症、低蛋白血症、美国麻醉师协会（American Society of Anesthesiologists, ASA）评分、术前血红蛋白（hemoglobin, Hb）、抗凝药物使用史、手术时间、融合节段、椎管减压方式等可能影响围手术期输血的危险因素,先后应用单因素分析和多元Logistic回归分析围手术期输血的独立危险因素。结果 468例病人中有61例（13%）发生输注红细胞事件。单因素分析显示年龄、性别、BMI、术前Hb水平、术前合并心脏疾病、低蛋白血症、骨质疏松症、术前使用抗凝药、ASA评分、融合节段、手术时间、术中出血量、术后引流量及术后并发症是输血事件发生的危险因素。多元Logistic回归分析结果提示,年龄≥66岁（OR=2.3,95%CI为1.2~4.7）、术前Hb≤125 g/L（OR=2.6,95%CI为1.3~5.1）、融合节段≥3个（OR=3.0,95%CI为1.4~6.3）、手术时间≥215 min（OR=4.0,95%CI为2.1~7.6）是增加围手术期输血事件发生的独立危险因素。结论 高龄、术前Hb偏低、多节段融合、手术时间过长的病人行腰椎后路融合内固定术围手术期输血风险较高,故在术前准备中应考虑上述预期输血的因素。     

围术期血液管理减少心脏外科手术中输血

目的回顾性分析围术期血液管理应用于心脏外科手术中减少输血的临床效果。方法本研究为回顾性研究,烟台毓璜顶医院2015年7月至2016年5月和2016年8月至2017年4月接受开胸心脏手术的患者106例,2015年7月至2016年5月的患者为对照组(n=49),采用常规管理;2016年8月—2017年4月的患者为研究组(n=57),采用围术期血液管理。比较两组术前基本信息、术中出血量和输血量,评估应用围术期血液管理的临床效果。结果两组术前红细胞、血红蛋白、血小板水平差异无统计学意义。研究组术中出血量明显少于对照组[(565.8±178.6)ml vs(734.1±278.7)ml,P0.05];研究组输异体红细胞比例明显低于对照组(1.8%vs 28.6%,P0.05);研究组输血浆比例明显低于对照组(10.5%vs 40.8%,P0.05);两组血小板和冷沉淀使用比例差异无统计学意义。结论围术期血液管理应用于心脏外科手术可以有效减少术中出血量,降低异体红细胞和血浆使用率。     

Use of red blood cell transfusions in surgery

Background: Limited blood supplies necessitate the rational use of blood products. The aim of the present study was to provide a basis for audits of red cell usage in surgery by benchmarking common practice. Application of the data to the construction of a maximum surgical blood order schedule may be relevant for centres that perform a serological crossmatch or who collect autologous units. Methods: Data on surgical procedures identified by Commonwealth Medical Benefits Schedule item numbers, were collected retro­spectively from theatre and blood bank records at the Royal Melbourne and Melbourne Private hospitals from May 1997 to April 1998. The percentage of procedures for which red cells were transfused, and the mean, median and range of units transfused for procedures with ≥ 30% transfusion likelihood were identified. Results: Over 12 months, 266 surgical procedure codes were itemized ≥ 10 times each, contributing 12 300 data entries. Only 38 procedures demonstrated an incidence of transfusion of at least 30%. Most frequently transfused procedures included spinal fusion, total hip replacement, mandible/maxilla resection, prostatectomy and bladder excision. Conclusion: The number of common surgical procedures in which there is a 30% or greater likelihood that red cell transfusions will be given is limited. This benchmarking of common red cell usage is a first step in the process of determination of transfusion appropriateness.     

Leukoreduction before red blood cell transfusion has no impact on mortality in trauma patients

BACKGROUND: Studies suggest that leukocytes in donated blood increase mortality and length of hospital stay (LOS) after transfusion. These studies included few trauma patients, however. Many institutions now mandate leukoreduction (LR) of transfusion products, which increases costs by approximately $30/unit. The purpose of this study was to examine the effect of LR on mortality and LOS in trauma patients. METHODS: A retrospective before-and-after cohort study was conducted at a level one urban trauma center. LR of all transfusion products commenced in January 2002. All patients treated within the intervention period (March 2002 through January 2004) received LR products. Those transfused during March 2000 through January 2002 served as controls. The trauma registry was queried for patients >or=18 years who survived >or=2 days and received >or=2 units of blood. Mortality and LOS were determined for each group. Subset analysis was performed on patients receiving 2-6 transfusions and those receiving massive transfusion (>or=6 units). Mortality and LOS for control and intervention subsets were compared. Means were compared using Student's t-test, proportions using chi(2) (significance P 相似文献   

Blood coagulation and autologous blood transfusion in cardiac surgery

Study Objective: To review the basic pathophysiology of altered coagulation associated with cardiopulmonary bypass and autologous blood transfusion in cardiac surgery.

Design: Review of rational use of heparin, mechanisms and treatment of coagulation disorders, and autologous blood transfusion.

Setting: Cardiac surgery in community and academic hospitals.

Patients: Adult cardiac surgical patients.

Main Results: Heparin is most commonly used for anticoagulation during cardiopulmonary bypass. Although activated clotting time is widely used to assess heparin-induced anticoagulation, the minimum time to prevent clotting during cardiopulmonary bypass remains unclear. Activated clotting time is affected by many factors other than heparin, such as antithrombin III, blood temperature, platelet count, and age. The rational use of activated clotting time still must be defined.

The frequency of abnormal bleeding after cardiopulmonary bypass is significant. Although inadequate surgical hemostasis is the most frequent cause of bleeding, altered coagulation often is present. A decreased number of functional platelets is one of the important causes of bleeding diathesis. Platelet dysfunction is induced by perioperative medication such as aspirin. Cardiopulmonary bypass decreases functional platelets by degranulation, fragmentation, and loss of fibrinogen receptors. Medications such as prostacyclin and iloprost may be useful to protect these platelets. Desmopressin increases factor VIII:C and von Willebrand's factor, leading to a decrease in bleeding time. Desmopressin may be useful to decrease blood loss in repeat cardiac operations, complex cardiac surgery, and abnormal postoperative bleeding.

Patients undergoing coronary artery bypass grafting immediately after streptokinase infusion also are at risk for abnormal bleeding. Transfusion of fresh frozen plasma and cryoprecipitate may be necessary.

Autologous blood transfusion is cost-effective and the safest way to avoid or decrease homologous blood transfusion. Predonation, intraoperative salvage, and postoperative salvage are encouraged. Erthroprotein may be useful in increasing the amount of predonation red cells.

Conclusions: Coagulation disorders in cardiac surgery are caused by many factors, such as heparin, platelet dysfunction, and fibronolysis. Rational use of blood component therapy and medications such as heparin, protamine, and desmorpessin are mandatory. Autologous blood transfusions is very useful in decreasing or obviating the use of homologous blood transfusion.     

Social and emotional factors as predictors of poor outcomes following cardiac surgery

 Open in a separate windowOBJECTIVESExisting risk prediction models in cardiac surgery stratify individuals based on their predicted risk, including only medical and physiological factors. However, the complex nature of risk assessment and the lack of parameters representing non-medical aspects of patients’ lives point towards the need for a broader paradigm in cardiac surgery. Objectives were to evaluate the predictive value of emotional and social factors on 4 outcomes; death within 90 days, prolonged stay in intensive care (≥72 h), prolonged hospital admission (≥10 days) and readmission within 90 days following cardiac surgery, as a supplement to traditional risk assessment by European System for Cardiac Operative Risk Evaluation (EuroSCORE).METHODSThe study included adults undergoing cardiac surgery in Denmark 2014–2017 including information on register-based socio-economic factors, and, in a nested subsample, self-reported symptoms of anxiety and depression. Logistic regression analyses were conducted, adjusted for EuroSCORE, of variables reflecting social and emotional factors.RESULTSAmongst 7874 included patients, lower educational level (odds ratio 1.33; 95% confidence interval 1.17–1.51) and living alone (1.25; 1.14–1.38) were associated with prolonged hospital admission after adjustment for EuroSCORE. Lower educational level was also associated with prolonged intensive care unit stay (1.27; 1.00–1.63). Having a high income was associated with decreased odds of prolonged hospital admission (0.78; 0.70–0.87). No associations or predictive value for symptoms of anxiety or depression were found on any outcomes.CONCLUSIONSSocial disparity is predictive of poor outcomes following cardiac surgery. Symptoms of anxiety and depression are frequent especially amongst patients with a high-risk profile according to EuroSCORE.Subj collection105, 123     

Factors influencing blood loss and allogeneic blood transfusion practice in craniosynostosis surgery

Objective/Aims: To identify factors influencing perioperative blood loss and transfusion practice in craniosynostotic corrections. Background: Craniosynostotic corrections are associated with large amounts of blood loss and high transfusion rates. Methods: A retrospective analysis was performed of all pediatric craniosynostotic corrections during the period from January 2003 to October 2009. The primary endpoint was the receipt of an allogeneic blood transfusion (ABT) during or after surgery. Pre‐, intra‐, and postoperative data were acquired using the electronic hospital registration systems and patients’ charts. Results: Forty‐four patients were operated using open surgical techniques. The mean estimated blood loss during surgery was 55 ml·kg^?1. In 42 patients, red blood cells were administered during or after surgery with a mean of 38 ml·kg^?1. In 23 patients, fresh frozen plasma was administered with a mean of 28 ml·kg^?1. A median of two different donors per recipient was found. Longer duration of surgery and lower bodyweight were associated with significantly more blood loss and red blood cell transfusions. Higher perioperative blood loss and surgery at an early age were correlated with a longer duration of admission. Conclusions: In this study, craniosynostotic corrections were associated with large amounts of blood loss and high ABT rates. The amount of ABT could possibly be reduced by appointing a dedicated team of physicians, by using new less‐invasive surgical techniques, and by adjusting anesthetic techniques.     

The impact of red blood cell storage duration on tissue oxygenation in cardiac surgery

Objective

Although storage alters red blood cells, several recent, randomized trials found no differences in clinical outcomes between patients transfused with red blood cells stored for shorter versus longer periods of time. The objective of this study was to see whether storage impairs the in vivo ability of erythrocytes to traverse the microcirculation and deliver oxygen at the tissue level.

Predictors of allogenic blood transfusion in elective cardiac surgery after preoperative autologous blood donation

Purpose  Preoperative autologous blood donation (PAD) is important for reducing exposure to allogenic blood in cardiac surgery. Unfortunately, even after PAD, allogenic blood transfusion is not always avoided. We investigated the predictors of blood component usage during elective cardiac surgery in patients prepared with PAD. Methods  Clinical data were collected for 143 consecutive patients (103 men and 40 women; mean age, 62 ± 9 years) who underwent elective cardiac surgery after PAD (959 ± 240 ml), often using iron supplement and recombinant human erythropoietin. Results  Allogenic blood transfusion was avoided during and after surgery in 107 patients (75%), whereas 36 patients required an allogenic transfusion (4.1 ± 3.8 U of packed red cells, 3.4 ± 4.1 U of fresh frozen plasma, and 5.8 ± 11.0 U of platelet concentrate). The independent factors for perioperative allogenic blood transfusion in these patients included the pre-donation hemoglobin value, the preoperative platelet count, and the lowest hemoglobin value during cardiopulmonary bypass. Conclusion  Even with PAD for elective cardiac surgery, patients whose pre-donation hemoglobin value and preoperative platelet count are low may require allogenic blood transfusion.     

心脏外科手术中应用自体血回收技术的血液保护效果Meta分析

目的 采用Meta分析评价心脏外科手术中应用血液回收技术的血液保护效果. 方法 计算机检索Cochrane 图书馆、PubMed、Embase、CINAHL以及中国知网数据库.收集关于心脏外科手术使用自体血回收的随机对照试验,按Cochrane 系统评价方法,评价所纳入研究的文献质量,并提取有效数据后采用RevMan 5.1软件进行Meta分析. 结果 纳入11项研究,共计2 046例患者.与对照组比较,应用血液回收技术能够减少围手术期红细胞的使用率[比值比(odda radio,OR)=0.68,95％置信区间(confidence interval,CI)(O.53,0.87)],减少围手术期新鲜冰冻血浆的使用率[OR=1.53,95％CI(1.02,2.31)],围手术期血小板的使用率差异无统计学意义[0R=0.86,95％CI (0.56,1.32)],术后并发症的发生率差异无统计学意义[OR=1.14,95％CI(0.92,1.41)]. 结论 心脏手术中使用自体血回收技术可以减少红细胞和新鲜冰冻血浆的输注,具有一定的血液保护效果,且不会增加术后并发症的发生率.     

骨科手术中自体血液回输对血清前炎性细胞因子浓度的影响

目的 测定下肢骨科手术术野回收血经自体血回收机处理前后及患者自血回输前后血清前炎性细胞因子浓度,观察骨科手术中自体血回输对患者细胞免疫的影响.方法 30例择期行下肢骨科手术患者,分别采集自体血回收机处理前后的术野回收血,并于自体血回输前10min、回输后1 h采集患者动脉血,采用放射酶联免疫吸附测量法测定血样中3种前炎性细胞因子白细胞介素(IL)-1β、IL-6、肿瘤坏死因子(TNF)浓度,并观察相关并发症.结果　术野回收血经自体血回收机处理前后3种前炎性细胞因子IL-1β、IL-6、TNF浓度分别为(0.54 ±0.22)、(0.71±0.16)、(16.23±5.68)μg/L和(0.26±0.12)、(0.29±0.09)、(6.32±2.57)μg/L,与处理前比较,处理后3种细胞因子浓度显著降低(P＜0.05);自血回输前后患者血清中3种细胞因子IL-1β、IL-6、TNF浓度分别为(0.35±0.17)、(0.47±0.15)、(8.44±3.56)μg/L和(0.39±0.19)、(0.52±0.18)、(9.48±3.45)μg/L,与回输前比较,回输后患者血清中3种细胞因子浓度增高(P＜0.05);30例患者自体血回输后12 h内均未观察到低血压、心动过速、血红蛋白尿、凝血功能紊乱、脓毒血症、空气栓塞、心肺问题等并发症.结论　骨科手术患者术中可适量自体血回输,回收血液经自体血回收机处理后前炎性细胞因子浓度显著降低,回输后未观察到严重并发症.

Abstract：

Objective To investigate the effects of autologous blood transfusion on serum cytokine levels in patients undergoing lower limb orthopedic surgery. Methods A total of 30 cases scheduled for undergoing lower limb orthopedic surgery were enrolled in this study. Each patient had four blood samples taken (pre-transfusion, one h post-transfusion, cell saver container, and post-filtration from the blood bag). An enzyme linked immunosorbent assay (ELISA) measurement of radiation was conducted to determine levels of the cytokines interleukin (IL)-1β, IL-6 and tumor necrosis factor (TNF). Serious complications and sequelae associated with autotransfusion were recorded. Results In comparison to cell saver container, levels of IL-1β, IL-6 and TNF in the blood bag were decreased significantly (P＜0. 05 ). In comparison to pre-transfusion, levels of IL-1β, IL-6 and TNF were increased significantly (P ＜ 0. 05 ). No serious complications and sequelae associated with autotransfusion were observed. Conclusion The use of cell saver container appears to be safe in patients undergoing orthopedic surgery and the levels of the cytokines in post-filtration blood are decreased.     

改良超滤对婴幼儿心脏手术输血的影响

目的　观察改良超滤技术在婴幼儿体外循环心血管手术中对输血及术后出血的影响。方法　 6 0例接受体外循环下心血管手术的先天性心脏病患儿 ,均分为对照组 (不接受任何超滤 )、常规超滤组 (CUF组 )和改良超滤组 (MUF组 )。观察术中库血用量、血浆用量、血球压积的变化及术后2 4h出血量 ,并用SSPS/PC进行统计学处理。结果　MUF组库血用量、血浆用量、术后 2 4h出血量显著低于对照组和CUF组 (P <0 0 1) ,且滤出水量明显多于CUF组 (P <0 0 1)。结论　在婴幼儿心血管手术中 ,改良超滤可有效排出体内水分 ,提高血球压积 ,明显减少输血及术后出血 ,是节约用血的重要手段之一。     

控制性降压联合自体血回输在脊柱手术中的应用

目的 探讨控制性降压联合自体血回输技术应用于复杂脊柱外科大手术的临床效果及安全性. 方法 将40例脊柱外科大手术的患者用抽签法随机分为两组(每组20例):控制性降压联合自体血回输组(A组)和非自体血回输组(B组).A组全麻诱导后,术中用硝酸甘油行控制性降压,维持平均动脉压(mean arterial pressure,MAP)(65±5) mmHg(1mmHg=0.133 kPa),并用血液回输仪回收术野出血;B组未行自体血回输;两组术中血细胞比容(hematocrit,Hct)低于25％即输库血.两组术中连续监测心率(heart rate,HR)、MAP、心电图(electrocardiogram,ECG)和中心静脉压(central venous pressure,CVP).记录两组患者术中出血量、异体输血量及输血相关并发症,术前和术后24 h红细胞(red blood cell,RBC)、血红蛋白(hemoglobin,Hb)、Hct、血小板(platelet,PLT)及凝血酶原时间(prothrombintime,PT)、活化部分凝血酶原时间(activeated partial thromboplasting time,APTT)和纤维蛋白原(fibrinogen,FG). 结果 A组出血量(1 120±510) ml与B组(1 524±457) ml比较,差异有统计学意义(P＜0.05);A组输异体血发生率(10％)显著少于B组(100％)(P＜0.01);术后24 h两组患者RBC、Hb、Hct、PLT、PT、APTT和FG与术前比较差异有统计学意义(P＜0.05),但都在正常范围内,两组间比较差异无统计学意义(P＞0.05);两组均无肺水肿、心力衰竭及创面异常出血并发症. 结论 控制性降压复合术中自体血回输在复杂脊柱手术中的应用是安全可靠的,能明显减少出血量,减少甚至避免异体血输入.